NCT05001139View on ClinicalTrials.gov

Clinical Investigation on the Efficacy and Safety of Relizema Ecofoam

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

December 29, 2022

Study Completion Date

June 15, 2023

Conditions
Dermatitis
Interventions
DEVICE

Relizema ecofoam

DermoRelizema ecofoam, class II a medical device, topical compact mousse, to be applied 2 times per day during the 42 days of study duration

Trial Locations (1)

95123

"AOU Policlinico G. Rodolico- San Marco", Catania

All Listed Sponsors
lead

Relife S.r.l.

INDUSTRY

NCT05001139 - Clinical Investigation on the Efficacy and Safety of Relizema Ecofoam | Biotech Hunter | Biotech Hunter